Top Buy
Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €707.60 | €766.92 | 8.383% |
Biogen Inc. | 46 | 1 | 6 | 1 | €205.20 | €294.01 | 43.280% |
Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €391.70 | €406.87 | 3.872% |
Alnylam Pharmace. | 36 | 0 | 3 | 0 | €138.75 | €236.30 | 70.305% |
Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €360.80 | €376.15 | 4.255% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 0 | €903.60 | €957.22 | 5.934% |
UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €473.95 | €543.72 | 14.721% |
Johnson & Johnson | 32 | 1 | 3 | 0 | €139.22 | €196.74 | 41.313% |
Pfizer Inc. | 31 | 4 | 3 | 0 | €26.06 | €41.10 | 57.724% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.00 | €124.93 | 3.247% |
Neurocrine Bioscience | 28 | 0 | 7 | 0 | €128.65 | €140.34 | 9.087% |
Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €79.82 | €88.14 | 10.420% |